Besides CRLs, NAE inhibition blocks the recruitment of the BRCA1 DNA damage repair complex and a combination with PARP inhibition inhibited cell growth of non-small cell lung cancer (NSCLC) cells [145]. Here, BRCA1 is linked to non-small cell lung carcinoma.